WASHINGTON, D.C. - On Monday, President Donald Trump signed an executive order giving drugmakers a deadline to lower the cost of prescription drugs in the US. The idea is to tie us drug prices to the lower prices you would find the same drug abroad, but that’s typically in government-run health systems. Some say this executive order is a shakeup to the industry, others say it’s a “bad deal” for Americans.
